Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 917 results for "sanofi"

SANOFI Sanofi and Regeneron to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014

Global Adhesion Barriers Market 2014-2018: Key Vendors are Bax...

Research and Markets ( has announced the addition of the "Global Adhesion Barriers Market 2014-2018" report to their offering. An adhesion barrier or anti-adhesion is a medical device ..., 1 day ago
Regeneron to announce drug study results for alirocumab Fairfield Business Journal, 14 hours ago

176 images for sanofi

American Banking News, 3 days ago
Pharma Letter, 1 day ago, 2 days ago
American Banking News, 5 days ago
San Francisco Chronicle, 5 days ago
Asian Scientist, 1 week ago
4 Traders, 1 week ago
ABC News 4 Charleston, 11 hours ago
FierceBiotech, 17 hours ago
CIO East Africa, 2 days ago

Amgen And Sanofi Compete To Launch New Class Of Cholesterol-Fighting Drugs

Amgen has filed a Biologics License Application with the FDA for a new class of cholesterol-fighting drugs. It is competing with Sanofi to be the first to tap into the $10 billion market Page 1 of 2 Click Ticker to See live coverage ...
 Bidness Etc23 hours ago Amgen files for US approval of cholesterol drug evolocumab28-08-2014  Pharma Letter21 hours ago Amgen submits next gen cholesterol drug  Pharmafocus21 hours ago Amgen submits PCSK9 inhibitor cholesterol drug to FDA for approval  MedCity News1 day ago

Pfizer Takes Lead Over Sanofi With Fast-Track Designation Of Its C. Difficile Vaccine

Pfizer has received the FDA's fast-track designation for its new CDI-preventive vaccine, and the designation has helped the company surge past its rival, Sanofi, which had been in the lead until now Page 1 of 2 Click Ticker to See live ...
 Bidness Etc22 hours ago Pfizer's C. diff vaccine gains on Sanofi with FDA fast-track nod  FierceVaccines1 day ago

Sanofi (SNY) Trading Near $55.73 Resistance Level

After closing Wednesday at $55.21, Sanofi-Aventis ("SNY) presents an attractive opportunity to get a 3.36% return in just 114 days, which is an annualized return of 10.77% (for comparison purposes ...
 Individual.com1 day ago Sanofi (SNY) Showing Bearish Technicals With Resistance At $53.30  Individual.com4 days ago

3 Reasons Sanofi's Stock Could Rise

After a rocky second quarter, biopharma stocks have rallied in a big way heading toward the end of the year. Gilead Sciences , for example, has shot up 41.5% year to date, with most of this upward movement coming in recent weeks. Even so, Sanofi ...
 Motley Fool1 day ago

Sanofi, Regeneron Take Lead In Cholestrol Drug Race

Sanofi and Regeneron unite in competition against Amgen, as the three struggle to become the pioneers of PCSK9 inhibiting cholesterol drug. This drug will be free from statins and hence, expected to improve the response rate of patients Page 1 ...
 Bidness Etc1 day ago Sanofi, Regeneron cholesterol drug may cut heart risk, trial hints  Reuters1 month ago Sanofi-Regeneron drug tames eczema in study  Reuters1 month ago Regeneron drug tames eczema in study  Reuters1 month ago

Fair Trade Regulator Gives Nod to Sanofi-Apollo Deal

New Delhi : The Competition Commission of India (CCI) has cleared pharmaceutical firm Sanofi-Synthelabo's proposed stake buy in an Apollo group arm, saying the deal does not raise any concerns related to unfair business practices. Under the ...
 NDTV Profit2 days ago CCI gives green signal to Sanofi-Apollo deal  Business Standard2 days ago

Sanofi and MannKind Partner to Bring Ultra-Rapid Inhaled Insulin Afrezza to Market by Early 2015

Twitter summary: New Sanofi & MannKind partnership to bring inhaled insulin Afrezza to US in early 2015, presumably primarily to type 2 patients to start On August 11, Sanofi and MannKind announced a partnership to bring MannKind's ...
 diaTribe1 day ago Sanofi and MannKind sign license agreement for new inhaled insulin therapy  Individual.com3 days ago Pharmaceutical Companies: Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) insulin human Rapid-Acting Inhaled Insulin  NewsRX2 days ago ViewPoints: Agree to disagree jury remains out on MannKind's Afrezza despite Sanofi deal  FirstWord Pharma2 days ago
Bio Spectrum Asia

Sanofi to license two of its pre-clinical drugs

Singapore : Sanofi is licensing two of its preclinical respiratory compounds to China's ZAI Lab, as per reports. Financial details of the deal have not been disclosed. The drugs show promise as potential treatments for chronic obstructive ...
 Bio Spectrum Asia2 days ago ZAI Lab Licenses Respiratory Disease Drugs From Sanofi  Asian Scientist1 week ago

(Special for CAFS) Sanofi to rollout cholera vaccination in Kenya in 2015

Contributed by NAMPA / Xinhua. NAIROBI, Aug. 27 (Xinhua) -- Pharmaceutical firm Sanofi is planning to rollout a cholera vaccine in Kenya in 2015. Sanofi Pasteur East and West African Region General Manager Paul Njoroge told a health forum in ...
 Namibia Press Agency2 days ago XINHUA - (Special for CAFS) Sanofi to rollout cholera vaccination in Kenya in 2015  Namibia Press Agency2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less